Sonoma Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Material agreementOct 6 →InsidersNo open-market buys or sales.→HoldersRenaissance Technologies 0.8%Geode 0.6%Vanguard 0.4%→Financing →PeersClosest companies: KRMD, HROW, DERM→
From the filings
Figures
- Revenue
- $21.9Mlast 12 months
- Net income
- −$2.3Mlast 12 months
- Operating cash flow
- −$2.6Mlast 12 months
- Cash and equivalents
- $5.3Mat the last balance sheet
- Total debt
- $140,000at the last balance sheet
- Shares outstanding
- 4.8M shareson issue